CHINA PHARMA HOLDINGS, INC. (CPHI) Free cash flow 2016–2025
CHINA PHARMA HOLDINGS, INC. (CPHI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$88,937FY2025 · since FY2016: $2.7M → $88,937
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $88,937 | +120.0% |
| FY2024 | -$444,474 | +37.5% |
| FY2023 | -$711,203 | +12.4% |
| FY2022 | -$811,509 | -18.0% |
| FY2021 | -$687,893 | +24.4% |
| FY2020 | -$909,567 | -292.6% |
| FY2019 | $472,309 | -74.2% |
| FY2018 | $1.8M | +159.8% |
| FY2017 | $704,737 | -73.9% |
| FY2016 | $2.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPHI financial trends
CPHI RevenueCPHI Net incomeCPHI Net marginCPHI Gross profitCPHI Gross marginCPHI Operating incomeCPHI Operating marginCPHI Operating cash flowCPHI Capital expendituresCPHI Return on equityCPHI Stock buybacksCPHI Dividends paidCPHI Total assetsCPHI Total liabilitiesCPHI Shareholders’ equityCPHI overview →